As New Yorkers patiently await the launch and operation of the adult cannabis market, the grey market is thriving. Initially, these pop-up shops and cannabis-infused food items appeared to make everything more convenient. They offered products from all over the country and many well-known brands, but do consumers really know if these products are authentic or if the cannabis is safe? The answer is certainly not.
According to the United States, just a few years ago this country experienced an electronic cigarette crisis where over 2,000 Americans were hospitalized due to lung-related illnesses linked to electronic smoking devices, and 60 people died as a result.
Investigators from the Centers for Disease Control and Prevention have found that the cause of the crisis is related to illegal products containing acetic acid and vitamin E.
The vast majority of products that have caused the electronic cigarette-related lung injury (EVALI) crisis were acquired on the street and contain additives. Unscrupulous individuals are using Vitamin E acetate to dilute tetrahydrocannabinol in e-cigarette cartridges, all for increased profit. So why aren't regulatory agencies taking more action to protect their fellow New Yorkers from potential serious health risks? Simply put, it's a thriving grey market.
Since the legalization of marijuana in New York in April 2021, the gray market has been allowed to thrive. Prior to the regulation, operators were not concerned about police possibly breaking down their doors and had unofficial licenses to sell whatever they wanted. A few months ago, these operators received cease and desist letters, warning them that if they didn't stop, they would be ineligible for official licenses.
However, members of the State Cannabis Management Office appear to be unaware that not everything is about money - what about the safety of consumers?
Electronic cigarettes are like all other products in the grey market - there is no knowledge about the ingredients in the pods, let alone any understanding of how the oil interacts with the various materials in the vaporizer, which turns the product into vapor that consumers inhale into their lungs.
Consumers cannot rely on the gray market to obtain these details. They need to be able to have a conversation with knowledgeable and reputable legitimate pharmacies that can provide them with the ingredients to make their own preferred extracts.
Consumers need to know which materials can leach out bisphenol A (BPA) and other products at higher temperatures, as well as whether their extracts are more alkaline or acidic. These factors could pose serious health risks for patients and consumers.
Another serious issue is the possibility of lead pollution. Traditionally, a material called H59 brass alloy, which contains slightly over 2% lead, has been used.
Manufacturers now claim that they are using a "lead-free" product, but this is another misconception. They mainly use a brass alloy called H59-B1 or B2, which contains only 0.5% lead but can still be leached out.
Any additional surface treatment on these materials, such as gold or black plating, may also contain lead.
Patients and consumers need to be aware of the risks associated with the products they are inhaling.
Many adults have accepted unbranded hardware as the norm in the medical market, and many no longer consider whether the product packaging clearly labels the contents.
New York regulatory agencies are being praised for their revolutionary approach towards establishing a fair and equitable cannabis market, and they should not be relegated to a secondary position within the Department of Homeland Security.
It's time to allow New Yorkers to rely on regulatory bodies to prioritize safety and to recognize that the gray market is simply a more appealing term for an illegal market. If action is not taken soon, they will ultimately face greater health issues rather than just law enforcement issues.
Statement:
This article has been compiled from third-party information and is intended for industry-related communication and learning purposes only.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is only intended for industry communication and research purposes.
Due to limitations in the translator's ability, the translated article may not fully express the original text. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and positions.
Article compilation and copyright belong to the original media and author. If there is a copyright infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
